A.   Provide another prescribed medication.

B.   Continue to monitor consciousness for 2 minutes.

C.   Administer a second dose.

D.   Administer four doses at 15-second intervals.

A.   Zaleplon

B.   Zolpidem

C.   Ramelteon

D.   Eszopiclone

A.   Relaxation

B.   Sleepwalking

C.   Dozing

D.   Deep sleep

A.   Sleepwalking

B.   Bedwetting

C.   Vivid dreams

D.   Daytime fatigue

A.   Short-acting barbiturates

B.   Long-acting barbiturates

C.   Ultra-short-acting barbiturates

D.   Intermediate-acting barbiturates

A.   Drug allergy

B.   Epileptic disease

C.   Cardiac disease

D.   Narrow-angle glaucoma

A.   Prevention of lightheadedness

B.   Reduction of choreiform movement

C.   Relief of nerve pain

D.   Reduction of muscle rigidity

A.   Increased perspiration

B.   Sleepwalking

C.   Increased body weight

D.   Bedwetting

A.   Midazolam

B.   Ramelteon

C.   Alprazolam

D.   Eszopiclone

A.   Cyclobenzaprine

B.   Baclofen

C.   Dantrolene

D.   Diazepam

A.   Amnesia

B.   Constipation

C.   Dry mouth

D.   Decreased heart rate

A.   Flumazenil

B.   Verapamil

C.   Olanzapine

D.   Rifampin

A.   The drug acts on gamma-aminobutyric acid (GABA) receptors in the central nervous system (CNS).

B.   The patient may need to be sedated to relieve symptoms of alcohol withdrawal.

C.   The drug acts on benzodiazepine receptors that play a role in alcohol addiction.

D.   The drug may reduce the memory of painful symptoms related to alcohol withdrawal.

A.   Phenobarbital

B.   Sulfamethoxazole

C.   Ceftriaxone

D.   Oxytocin

A.   Mephobarbital

B.   Pentobarbital

C.   Phenobarbital

D.   Butabarbital

A.   Decreased benzodiazepine effects

B.   Increased daytime sleepiness

C.   Increased central nervous system (CNS) depression

D.   Prolonged benzodiazepine action

A.   Furosemide

B.   Activated charcoal

C.   Flumazenil

D.   Olanzapine

A.   Presence of benzodiazepine receptors adjacent to the receptors responsible for alcohol addiction

B.   Suppression of gamma-aminobutyric acid (GABA) receptors

C.   Inhibition of nerve impulse transmission

D.   Amnesic properties

A.   Recommending that the patient consume a glass of warm lactose-free milk at bedtime

B.   Instructing the patient to take low doses of benzodiazepines

C.   Encouraging the patient to maintain a well-balanced diet

D.   Teaching the patient about meditation

A.   Phenylephrine at a maximum dose of 5 mg

B.   Flumazenil at a maximum dose of 1 mg

C.   Phenylephrine at a maximum dose of 2 mg

D.   Flumazenil at a maximum dose of 3 mg

A.   The patient is experiencing benzodiazepine toxicity.

B.   The patient is experiencing a barbiturate overdose.

C.   The patient is experiencing a muscle-relaxant overdose.

D.   The patient was administered azole along with benzodiazepine.

A.   Ramelteon

B.   Pentobarbital

C.   Zaleplon

D.   Diazepam

A.   Avoiding tobacco at bedtime

B.   Sleeping more during the day

C.   Establishing a set sleep pattern

D.   Avoiding alcohol at bedtime

A.   Temazepam

B.   Diazepam

C.   Flurazepam

D.   Midazolam

A.   Hallucinations

B.   Alertness

C.   Ataxia

D.   Dyspnea

A.   Activated charcoal

B.   Naloxone

C.   Ipecac syrup

D.   Flumazenil

A.   Dose of the drug used to produce the effect on the CNS

B.   Duration of action on the central nervous system (CNS)

C.   Degree of patient responsiveness to the drug given

D.   Degree of inhibition of nerve impulse transmission to the CNS

A.   Temazepam induces sleep in approximately 1 hour.

B.   The therapeutic activity of temazepam is reduced with sleep.

C.   Temazepam may cause gastrointestinal upset.

D.   Temazepam causes early awakening after sleep.

A.   Infusion that is too rapid

B.   Intravenous infiltration

C.   Infusion of other drugs

D.   Infusion without dilution

A.   Go to acupuncture therapy.

B.   Take lower doses of benzodiazepines.

C.   Use home remedies of vegetables and herbs.

D.   Drink lactose-free milk at bedtime.

A.   Diazepam, Midazolam, Eszopiclone

B.   Zolpidem, Ramelteon, Eszopiclone

C.   Zolpidem, Diazepam, Midazolam

D.   Diazepam, Ramelteon, Midazolam

A.   Administration of activated charcoal

B.   Administration of furosemide

C.   Maintenance of an adequate airway

D.   Administration of intravenous fluids

A.   "I may be prescribed benzodiazepines to promote sleep."

B.   "I will have a glass of warm milk before bed."

C.   "I will stop drinking coffee at least 6 hours before bedtime."

D.   "I should avoid exercise just before going to bed."

A.   Request a prescription to increase the dosage of pentobarbital.

B.   Instruct the patient to increase the dosage of the contraceptive drug.

C.   Suggest an alternate contraceptive method to the patient.

D.   Recommend discussing an alternative drug for seizures with the primary health care provider.

A.   Respiratory arrest

B.   Delirium tremens

C.   Tonic-clonic seizure

D.   Malignant hyperthermia

A.   Drink coffee or tea in the morning.

B.   Avoid using this drug to induce sleep.

C.   Use the lowest effective dosage.

D.   Take the drug 30 minutes before sleeping.

A.   Increases pain associated with activities

B.   Impairs coordinated movements

C.   Causes gastrointestinal distress

D.   Produces drowsiness, lethargy, and blurred vision

A.   Thiopental

B.   Phenobarbital

C.   Pentobarbital

D.   Butabarbital

A.   Pregnancy, Drug allergy, Significant respiratory difficulties

B.   Hypotension, Status epilepticus, Pregnancy

C.   Significant respiratory difficulties, Hypotension, Status epilepticus

D.   Hypotension, Drug allergy, Status epilepticus

A.   "Expect and prepare for a daytime hangover."

B.   "Take the medication with food or milk."

C.   "Allow at least 8 hours for sleep."

D.   "Report palpitations to the primary health care provider."

A.   Takes olanzapine along with diazepam

B.   Drinks grapefruit juice along with diazepam

C.   Takes rifampin along with diazepam

D.   Takes phenobarbital along with diazepam

A.   Monoamine oxidase inhibitor (MAOI), Selective serotonin reuptake inhibitor (SSRI), Serotonin-norepinephrine reuptake inhibitor (SNRI)

B.   Tricyclic antidepressant, Monoamine oxidase inhibitor (MAOI), Atypical antidepressants

C.   Selective serotonin reuptake inhibitor (SSRI), Tricyclic antidepressant, Serotonin-norepinephrine reuptake inhibitor (SNRI)

D.   Selective serotonin reuptake inhibitor (SSRI), Serotonin-norepinephrine reuptake inhibitor (SNRI), Atypical antidepressants

A.   Kidney dysfunction

B.   Narrow-angle glaucoma

C.   Liver dysfunction

D.   Bronchial asthma

A.   Eszopiclone

B.   Temazepam

C.   Alprazolam

D.   Clonazepam

A.   Baclofen

B.   Diazepam

C.   Zaleplon

D.   Pentobarbital

A.   Monitoring for suicidal tendencies

B.   Monitoring the patient’s renal and hepatic function

C.   Assessing the patient’s risk for injury or falls

D.   Encouraging the patient to drink more fluids

A.   Seizure precautions

B.   Comfort measures

C.   Antidote preparation

D.   Airway maintenance

A.   Muscle spasms

B.   Indicators of infection

C.   Level of consciousness

D.   Amount of bleeding

A.   A high dose of flumazenil was given.

B.   Alcohol was consumed with the benzodiazepines.

C.   0.2 mg (2 mL) of flumazenil was given intravenously (IV).

D.   The half-life of flumazenil is short.

A.   Eszopiclone

B.   Zaleplon

C.   Alprazolam

D.   Ramelteon

A.   "I often feel dizzy and lightheaded."

B.   "Nowadays I sleep for long hours."

C.   "I sleep less than I used to."

D.   "I feel like I breathe too deeply."

A.   0.5 mg (5 mL) IV over 30 seconds

B.   0.2 mg (2 mL) IV over 60 seconds

C.   0.2 mg (2 mL) IV over 15 seconds

D.   0.2 mg (2 mL) intravenously (IV) over 30 seconds